Jupiter Neurosciences Inc - JUNS Quarterly EPS earnings growth

Brandmark of jupiterneurosciences.com (JUNS)

The monopoly potential driven by the resveratrol platform in Alzheimer's therapy could provide Jupiter Neurosciences Inc (JUNS) with significant pricing power. The quarterly EPS growth snapshot reflects this efficiency, where 20.00 represents the current level of the metric. Operational risks are minimized through the outsourcing of molecule synthesis, while the development strategy relies on finding a licensee to buy out the rights to the neuroplatform.

jupiterneurosciences.com (JUNS) Year-over-year earnings per one share growth for the last 12 months: for the period 12/04/2024 - 11/14/2026

Comprehensive metric breakdowns and analytics for Jupiter Neurosciences Inc (JUNS)

- share price and consensus valuation forecast:
Stock Quotes Jupiter Neurosciences|JUNS - Analyst Forecast Prices
- issuer market value details:
Market Capitalization Jupiter Neurosciences|JUNS - Total Enterprise Value
- balance sheet net asset value indicators:
Net Assets per Single Share Jupiter Neurosciences|JUNS - Accounting Value of Company|Market Cap to Net Assets Ratio jupiterneurosciences.com|JUNS - Aggregate Asset Value
- company liabilities and liquidity data:
Debt to Equity Jupiter Neurosciences Inc|JUNS - Long-Term Debt to Capital Ratio|Short-Term Debt to Capital jupiterneurosciences.com|JUNS - Company Cumulative Debt|Debt to Book Value Jupiter Neurosciences Inc|JUNS - Company Long-Term Debts|Company Short-Term Debt Jupiter Neurosciences|Quick Liquidity jupiterneurosciences.com
- earnings and market multiples details:
JUNS - Company Net Income|Expected Profit Jupiter Neurosciences Inc|JUNS - Business Payback Period|Forward P/E Multiple jupiterneurosciences.com|JUNS - Price/Earnings to Growth Multiple|EV/EBITDA Multiple Jupiter Neurosciences, Inc.|JUNS - Operating income before deduction of amortization|Net earnings per share (EPS TTM) Jupiter Neurosciences|JUNS - Net earnings per one share for the last twelve months|Year-over-year earnings per share growth for the last twelve months jupiterneurosciences.com|JUNS - Earnings per share growth this year|Earnings growth forecast for next year Jupiter Neurosciences Inc
- sales revenue and business income indicators:
JUNS - Company Sales|Projected Sales Volume jupiterneurosciences.com|JUNS - Price to Sales|Price-to-Projected Revenue Ratio Jupiter Neurosciences, Inc.
Comprehensive company analysis:Jupiter Neurosciences, Inc., JUNS
Manufactured product of Jupiter Neurosciences, Inc.

To select assets with a high margin of safety, analyzing earnings per share (EPS) dynamics is critical, as it measures the impact of operating expenses on net margins through quarter-over-quarter percentage changes. In the case of Jupiter Neurosciences Inc (JUNS), this quarterly EPS trend reflects the company's financial resilience during the pre-commercial stage of developing neuroinflammation drugs, where the absence of revenue turns this metric into an indicator of capital management efficiency.

Competitor analysis

BIIB: Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Neurocrine Biosciences Inc (NBIX)|RGC (Regencell Bioscience Ltd) - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months Axsome Therapeutics, Inc. AXSM|Year-over-year net earnings per share growth for the last 12 months ACAD (ACADIA Pharmaceuticals Inc.)|XENE: Year-over-year net earnings per share trend for the last twelve months|Viking Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|Year-over-year net earnings per share change for the last twelve months Supernus Pharmaceuticals (SUPN)|CPRX: Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per one share growth for the last 12 months DNLI (Denali Therapeutics)|HRMY: Quarterly EPS earnings growth|BHVN (Biohaven Pharmaceutical) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months Amylyx|Quarterly EPS earnings growth Trevi Corp|Quarterly EPS earnings growth PRAX|AVXL (anavex.com) - Year-over-year earnings per one share growth for the last 12 months|CeriBell Inc - Year-over-year net earnings per share growth for the last 12 months|PRTA (Prothena Corporation plc) - Year-over-year net earnings per share trend for the last twelve months|ALEC - Year-over-year earnings per share growth for the last twelve months|ANNX (Annexon Biosciences Inc.) - Year-over-year earnings per share growth for the last 12 months|OMER (omeros.com) - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth for the last 12 months NGNE|Year-over-year net earnings per share growth for the last 12 months ACIU|Quarterly EPS earnings growth Voyager Pharma|Year-over-year net earnings per share growth for the last 12 months NMRA (Neumora Therapeutics, Inc.)|SCLX - Earnings per share growth in annualized terms for the last twelve months|Year-over-year earnings per share growth for the last twelve months Tevogen Bio TVGN|Alpha Cognition Corp (ACOG) - Earnings per share growth in annualized terms for the last twelve months|CGTX: Year-over-year net earnings per share growth for the last 12 months|Inhibikase Therapeutics, Inc. - Year-over-year earnings per share growth rate for the last twelve months|SAVA: Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last 12 months ASRT|COYA (coyatherapeutics.com) - Quarterly EPS earnings growth|Vistagen (VTGN) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months OVID (Ovid Rx)|Year-over-year net earnings per share change for the last twelve months Acumen Pharmaceuticals, Inc.|Quarterly EPS earnings growth CRVO (CervoMed Corporation)|Year-over-year earnings per share growth rate for the last twelve months ATHE (Alterity Therapeutics Ltd)|Clene Nanomedicine - Quarterly EPS earnings growth|Net earnings per share growth for the trailing year pepgen.com (PEPG)|Relmada (RLMD) - Year-over-year earnings per share growth for the last twelve months|Earnings per share growth in annualized terms for the last twelve months Annovis Bio (ANVS)|GRCE (gracetx.com) - Quarterly EPS earnings growth|Firefly Neuroscience Inc (AIFF) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months KLTO (Klotho Neurosciences Inc)|NeuroSense Therapeutics Ltd - Year-over-year earnings per share growth for the last 12 months|Quarterly EPS earnings growth RVPH (Reviva Pharmaceuticals, Inc.)|Year-over-year earnings per one share growth for the last 12 months MTVA|NeurAxis Inc - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Helius Medical Technologies, Inc. HSDT|PASG: Quarterly EPS earnings growth|Neuphoria (NEUP) - Quarterly EPS earnings growth|Year-over-year earnings per share growth for the last twelve months Minerva Neurosciences Inc|Athira Pharma Inc (ATHA) - Year-over-year net earnings per share change for the last twelve months|Year-over-year net earnings per share growth for the last 12 months ADXN (Addex Therapeutics)|Quarterly EPS earnings growth Alzamend Neuro Inc. (ALZN)|Cyclerion Therapeutics, Inc. - Year-over-year net earnings per share growth for the last 12 months|PTIX (Protagenic Therapeutics) - Year-over-year net earnings per share trend for the last twelve months|Pasithea Therapeutics Corp - Quarterly EPS earnings growth|Year-over-year net earnings per share change for the last twelve months Cortigent CRGT|ATXI (Avenue Therapeutics, Inc) - Year-over-year net earnings per share growth for the last 12 months|Brainstorm Cell Therapeutics, Inc. - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months CARA|Earnings per share growth in annualized terms for the last twelve months chromocell.com CHRO|Year-over-year earnings per share growth for the last twelve months Eliem Therapeutics, Inc. (ELYM)|ITCI (Intra-Cellular Therapies, Inc.) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth LBPH (Longboard Pharmaceuticals Inc)|Quarterly EPS earnings growth Marinus Pharma MRNS|nkgenbiotech.com - Quarterly EPS earnings growth|Earnings per share growth in annualized terms for the last twelve months NeuroBo Pharmaceuticals, Inc.|Sage Therapeutics (SAGE) - Year-over-year earnings per share growth for the last twelve months|SNPX - Year-over-year net earnings per share change for the last twelve months|Year-over-year earnings per share growth for the last twelve months Trevena, Inc|Vigil Neuroscience (VIGL) - Year-over-year net earnings per share change for the last twelve months|Quarterly EPS earnings growth WENA|Quarterly EPS earnings growth cerevel.com (CERE)